Apogee Therapeutics, Inc. Common Stock (APGE) is a publicly traded Healthcare sector company. As of July 11, 2026, APGE trades at $133.65 with a market cap of $10.04B and a P/E ratio of -31.66. APGE moved +0.06% today. Year to date, APGE is +77.07%; over the trailing twelve months it is +246.51%. Its 52-week range spans $26.20 to $133.87. Analyst consensus is neutral with an average price target of $127.95. Rallies surfaces APGE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Apogee Therapeutics, Inc. Common Stock (APGE) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. APGE moved +0.06% today. Analyst consensus is neutral.
| Metric | Value |
|---|---|
| Price | $133.65 |
| Market Cap | $10.04B |
| P/E Ratio | -31.66 |
| EPS | $-4.22 |
| Dividend Yield | 0.00% |
| 52-Week High | $133.87 |
| 52-Week Low | $26.20 |
| Volume | 659.08K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-255.84M |
| Gross Margin | 0.00% |
16 analysts cover APGE: 0 strong buy, 4 buy, 12 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $127.95.